Compoundeer Logo
COMPOUNDEER
Uncovering Potential
RankingCompaniesDCF
DHR Logo

Danaher Corp

DHR

Industrial Instruments For Measurement, Display, and Control

Mkt Cap

$201.6B

PE

34.33

Debt

$24.61B

Cash

$12.28B

EV

$214B

FCF

$6.776B

Market Cap

$201.6B

P/E Ratio

34.33

Debt

$24.61B

Cash

$12.28B

EV

$214B

FCF

$6.776B
Charts data: {"Earnings":[{"time":"2014-12-30","value":2598400000},{"time":"2015-12-30","value":3357400000},{"time":"2016-12-30","value":2553700000},{"time":"2017-12-30","value":2492100000},{"time":"2018-12-30","value":2650900000},{"time":"2019-12-30","value":2939800000},{"time":"2020-12-30","value":3510000000},{"time":"2021-12-30","value":6269000000},{"time":"2022-12-30","value":7103000000}],"Sales":[{"time":"2014-12-30","value":19913800000},{"time":"2015-12-30","value":20563100000},{"time":"2016-12-30","value":16882400000},{"time":"2017-12-30","value":18329700000},{"time":"2018-12-30","value":19893000000},{"time":"2019-12-30","value":17911100000},{"time":"2020-12-30","value":22284000000},{"time":"2021-12-30","value":29453000000},{"time":"2022-12-30","value":31471000000}],"Net Margins":[{"time":"2014-12-30","value":0.13048237905372154},{"time":"2015-12-30","value":0.1632730473518098},{"time":"2016-12-30","value":0.15126403828839502},{"time":"2017-12-30","value":0.13595967200772516},{"time":"2018-12-30","value":0.13325792992509927},{"time":"2019-12-30","value":0.16413285616182144},{"time":"2020-12-30","value":0.15751211631663975},{"time":"2021-12-30","value":0.21284758768206974},{"time":"2022-12-30","value":0.22569985065615963}],"Assets":[{"time":"2014-12-30","value":36991700000},{"time":"2015-12-30","value":48222200000},{"time":"2016-12-30","value":45295300000},{"time":"2017-12-30","value":46648600000},{"time":"2018-12-30","value":47832500000},{"time":"2019-12-30","value":62081600000},{"time":"2020-12-30","value":76161000000},{"time":"2021-12-30","value":83184000000},{"time":"2022-12-30","value":84350000000}],"Stockholders Equity":[{"time":"2014-12-30","value":23449800000},{"time":"2015-12-30","value":23764000000},{"time":"2016-12-30","value":23076800000},{"time":"2017-12-30","value":26367800000},{"time":"2018-12-30","value":28226700000},{"time":"2019-12-30","value":30281900000},{"time":"2020-12-30","value":39777000000},{"time":"2021-12-30","value":45177000000},{"time":"2022-12-30","value":50090000000}],"ROE":[{"time":"2014-12-30","value":0.11080691519757098},{"time":"2015-12-30","value":0.141280929136509},{"time":"2016-12-30","value":0.11066092352492547},{"time":"2017-12-30","value":0.09451300449791034},{"time":"2018-12-30","value":0.09391462693123886},{"time":"2019-12-30","value":0.09708109464729756},{"time":"2020-12-30","value":0.08824194886492194},{"time":"2021-12-30","value":0.1387653009274631},{"time":"2022-12-30","value":0.14180475144739468}],"ROA":[{"time":"2014-12-30","value":0.09412381696434606},{"time":"2015-12-30","value":0.07193989490317737},{"time":"2016-12-30","value":0.060732570487445715},{"time":"2017-12-30","value":0.06476507333553419},{"time":"2018-12-30","value":0.07116082161710134},{"time":"2019-12-30","value":0.053241218009845104},{"time":"2020-12-30","value":0.05901970824962908},{"time":"2021-12-30","value":0.09133968070782843},{"time":"2022-12-30","value":0.10299940723177238}]}

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Sector

  • AME Logo

    AME

  • CGNX Logo

    CGNX

  • FTV Logo

    FTV

  • KEYS Logo

    KEYS

  • MKSI Logo

    MKSI

  • MLAB Logo

    MLAB

Growth

%

%

Discount

%

%

Multiple

g\r+10%+11%+12%+13%+14%
0%109887
+1%1110988
+2%13111098
+3%141311109
+4%1714121110
Years012345678910TV
FCF$6.776B$7.693B$8.662B$9.67B$10.7B$11.75B$12.78B$13.78B$14.73B$15.61B$16.39B$163.9B
DCF$6.69B$6.55B$6.358B$6.12B$5.841B$5.525B$5.182B$4.817B$4.437B$4.052B$40.52B
Value$96.09B

In the chart Earnings are multiplied by this value.

Earnings Growth 13%
Earnings Stability 63%


Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12-201412-201512-201612-201712-201812-201912-202012-202112-2022TTM
Net Margin13%16%15%14%13%16%16%21%23%20%
ROA9.4%7.2%6.1%6.5%7.1%5.3%5.9%9.1%10%7.9%
ROE11%14%11%9.5%9.4%9.7%8.8%14%14%11%

What is the average Net Margin?

The average Net Margin over the past 5 years is +17.16%.

What is the trend of Net Margin?

The trend of Net Margin over the past 5 years is +1.95%.

What is the average Return on Assets (ROA)?

The average ROA over the past 5 years is +7.38%.

What is the trend of Return on Assets (ROA)?

The trend of ROA over the past 5 years is +0.74%.

What is the average Return on Equity (ROE)?

The average ROE over the past 5 years is +10.91%.

What is the trend of Return on Equity (ROE)?

The trend of ROE over the past 5 years is +1.03%.


Safety & Stabiliy

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12-201412-201512-201612-201712-201812-201912-202012-202112-2022TTM
Debt FCF-4.295.073.752.916.623.913.142.753.63
Debt Equity0.150.580.640.410.350.720.530.490.400.47
MIN
Graham Stability---88%95%100%100%100%100%88%

What is the Debt/FCF?

The Debt/FCF trailing twelve month is 3.63.

What is the trend of Debt/FCF?

The trend of Debt/FCF over the past 5 years is -0.20.

What is the Graham’s Stability?

Graham’s Stability measure stands at 0.88.


Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12-201512-201712-201912-2021Trend
Revenue6.3%11%21%6.9%3.6%
Net Income11%23%34%13%5.6%
Stockholders Equity11%14%18%11%2.4%
FCF13%21%30%4.3%4.7%

What is the 5 year Revenue CAGR?

The Revenue CAGR over the past 5 years is +11.42%.

What is the trend of Revenue growth?

The trend of Revenue growth rate over the past 5 years is +3.63%.

What is the 5 year Earnings CAGR?

The Earnings CAGR over the past 5 years is +23.3%.

What is the trend of Earnings growth?

The trend of Earnings growth rate over the past 5 years is +5.61%.

What is the 5 year Equity CAGR?

The Equity CAGR over the past 5 years is +13.69%.

What is the trend of Equity growth?

The trend of Equity growth rate over the past 5 years is +2.39%.

What is the 5 year FCF CAGR?

The FCF CAGR over the past 5 years is +20.85%.

What is the trend of FCF growth?

The trend of FCF growth rate over the past 5 years is +4.69%.